S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
NYSE:HRC

Hill-Rom Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$155.96
0.00 (0.00%)
(As of 12/13/2021)
Add
Compare
Today's Range
$155.96
$155.96
50-Day Range
$155.05
$156.18
52-Week Range
$93.34
$156.22
Volume
N/A
Average Volume
656,912 shs
Market Capitalization
$10.30 billion
P/E Ratio
41.92
Dividend Yield
0.62%
Beta
0.55

Receive HRC News and Ratings via Email

Sign-up to receive the latest news and ratings for Hill-Rom and its competitors with MarketBeat's FREE daily newsletter.


Hill-Rom logo

About Hill-Rom

Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
43147510
Employees
10,000
Year Founded
N/A

Sales & Book Value

Annual Sales
$3.02 billion
Cash Flow
$9.29 per share
Book Value
$28.56 per share

Profitability

Net Income
$248.50 million
Pretax Margin
10.03%

Debt

Price-To-Earnings

Miscellaneous

Free Float
65,594,000
Market Cap
$10.30 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/05/2021
Ex-Dividend for 12/31 Dividend
12/14/2021
Dividend Payable
12/31/2021
Today
1/17/2022
Next Earnings (Estimated)
2/04/2022
Fiscal Year End
9/30/2022

MarketRank

Overall MarketRank

2.51 out of 5 stars

Medical Sector

120th out of 1,405 stocks

Surgical & Medical Instruments Industry

16th out of 130 stocks

Analyst Opinion: 1.1Community Rank: 4.4Dividend Strength: 3.3Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -












Hill-Rom (NYSE:HRC) Frequently Asked Questions

Is Hill-Rom a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hill-Rom in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Hill-Rom stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HRC, but not buy additional shares or sell existing shares.
View analyst ratings for Hill-Rom
or view top-rated stocks.

When is Hill-Rom's next earnings date?

Hill-Rom is scheduled to release its next quarterly earnings announcement on Friday, February 4th 2022.
View our earnings forecast for Hill-Rom
.

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) issued its quarterly earnings results on Friday, November, 5th. The medical technology company reported $1.67 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.47 by $0.20. The medical technology company earned $797.90 million during the quarter, compared to analyst estimates of $752.97 million. Hill-Rom had a net margin of 8.23% and a trailing twelve-month return on equity of 23.07%. The business's quarterly revenue was up 13.1% on a year-over-year basis. During the same quarter last year, the company posted $1.17 EPS.
View Hill-Rom's earnings history
.

How often does Hill-Rom pay dividends? What is the dividend yield for Hill-Rom?

Hill-Rom declared a quarterly dividend on Tuesday, November 2nd. Stockholders of record on Wednesday, December 15th will be given a dividend of $0.24 per share on Friday, December 31st. This represents a $0.96 annualized dividend and a dividend yield of 0.62%. The ex-dividend date is Tuesday, December 14th.
View Hill-Rom's dividend history
.

Is Hill-Rom a good dividend stock?

Hill-Rom pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.62%. Hill-Rom has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Hill-Rom is 25.81%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Hill-Rom will have a dividend payout ratio of 13.37% next year. This indicates that Hill-Rom will be able to sustain or increase its dividend.
View Hill-Rom's dividend history.

What price target have analysts set for HRC?

6 brokers have issued 12-month price objectives for Hill-Rom's stock. Their forecasts range from $122.00 to $156.00. On average, they expect Hill-Rom's stock price to reach $144.00 in the next twelve months. This suggests that the stock has a possible downside of 7.7%.
View analysts' price targets for Hill-Rom
or view top-rated stocks among Wall Street analysts.

Who are Hill-Rom's key executives?

Hill-Rom's management team includes the following people:
  • John P. Groetelaars, President, Chief Executive Officer & Director
  • Tim Lawrence, Senior Vice President-Operations
  • Barbara W. Bodem, Chief Financial Officer & Senior Vice President
  • Brian L. Lawrence, Chief Technology Officer & SVP-Innovation
  • Ilana Shulman, Chief Compliance Officer

What is John P. Groetelaars' approval rating as Hill-Rom's CEO?

54 employees have rated Hill-Rom CEO John P. Groetelaars on Glassdoor.com. John P. Groetelaars has an approval rating of 82% among Hill-Rom's employees.

What other stocks do shareholders of Hill-Rom own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), NVIDIA (NVDA), Square (SQ), PayPal (PYPL), salesforce.com (CRM), CVS Health (CVS), Micron Technology (MU), AbbVie (ABBV) and Bank of America (BAC).

What is Hill-Rom's stock symbol?

Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."

What is Hill-Rom's stock price today?

One share of HRC stock can currently be purchased for approximately $155.96.

How much money does Hill-Rom make?

Hill-Rom has a market capitalization of $10.30 billion and generates $3.02 billion in revenue each year. The medical technology company earns $248.50 million in net income (profit) each year or $3.72 on an earnings per share basis.

How many employees does Hill-Rom have?

Hill-Rom employs 10,000 workers across the globe.

What is Hill-Rom's official website?

The official website for Hill-Rom is www.hill-rom.com.

Where are Hill-Rom's headquarters?

How can I contact Hill-Rom?

Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The medical technology company can be reached via phone at (312) 819-7200, via email at [email protected]m, or via fax at 812-934-8189.


This page was last updated on 1/17/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.